Author:
Ma Yuxiang,Lin Yuehao,Zou Benyan,Liu Wanli,Zhang Yang,Zhao Liping,Huang Yan,Yang Yunpeng,Fang Wenfeng,Zhao Yuanyuan,Sheng Jin,Qin Tao,Hu Zhihuang,Zhang Li,Zhao Hongyun
Funder
National Natural Science Foundation of China
Molecular Classification, Personalized Diagnosis and Therapy of Nasopharyngeal Carcinoma
National High Technology Research and Development Program of China
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference56 articles.
1. Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet. 1997;350(9084):1087–91.
2. Zhang LF, Li YH, Xie SH, et al. Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis. Chin J Cancer. 2015;34(8):350–7.
3. Cao SM, Xu YJ, Lin GZ, et al. Estimation of cancer burden in Guangdong Province, China in 2009. Chin J Cancer. 2015;34(3):58.
4. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365(9476):2041–54.
5. Li YH, Wang FH, Jiang WQ, et al. Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma. Cancer Chemother Pharmacol. 2008;62(3):539–44.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献